New facets of antifungal therapy

Ya-Lin Chang1, Shang-Jie Yu1, Joseph Heitman2

  • 1a Department of Plant Pathology and Microbiology , National Taiwan University , Taipei , Taiwan.

Virulence
|November 8, 2016
PubMed

Insights

New antifungal therapies, including novel formulations and combination treatments, offer hope for improving outcomes in invasive fungal infections, addressing limitations of current options.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Mycology

Background:

  • Invasive fungal infections (IFIs) are a significant cause of illness and death in immunocompromised individuals.
  • Current antifungal treatments (polyenes, triazoles, echinocandins) have limitations including narrow spectrum, resistance, and toxicity.
  • Existing therapies often suffer from poor clinical efficacy and variable pharmacokinetic properties.

Purpose of the Study:

  • To review advancements in antifungal therapy.
  • To highlight new antifungal formulations and their potential benefits.
  • To explore the synergistic effects of combination antifungal drug regimens.

Main Methods:

  • Literature review of current and emerging antifungal strategies.
  • Discussion of novel antifungal agents and formulations.
  • Analysis of combination therapy principles and synergistic interactions.

Main Results:

  • New antifungal agents and formulations are under development to overcome limitations of existing drugs.
  • Combination therapies show promise for enhanced efficacy and broader spectrum of activity.
  • Therapeutic drug monitoring for antifungals may offer benefits but requires further data.

Conclusions:

  • Novel antifungal formulations and combination regimens are crucial for improving patient care.
  • Addressing limitations of current antifungals requires continued research into new therapeutic approaches.
  • Future strategies may involve personalized medicine and optimized drug combinations for invasive fungal diseases.

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
59
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
667
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.1K
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
364
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.7K
Overview of Fungi01:29

Overview of Fungi

Fungi are a diverse group of eukaryotes more closely related to animals than other eukaryotes. Fungal cell walls comprise chitin, a polysaccharide that provides structural strength, and glucans, which contribute to flexibility and integrity. Other polysaccharides, such as mannans and galactosans, may supplement or replace chitin in some fungi. These adaptations, along with their preference for acidic environments and tolerance for high osmotic pressure, enable fungi to thrive in various...
2.2K